Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney Cancer
Condition(s):Kidney CancerLast Updated:June 15, 2015Terminated
Hide Studies Not Open or Pending
Condition(s):Kidney CancerLast Updated:June 15, 2015Terminated
Condition(s):Melanoma Brain MetastasesLast Updated:December 27, 2023Not yet recruiting
Condition(s):HCC – Hepatocellular Carcinoma; Metastatic Cancer; Metastatic TumorLast Updated:December 29, 2022Not yet recruiting
Condition(s):Renal Cell CarcinomaLast Updated:August 10, 2018Unknown status
Condition(s):Ovarian NeoplasmsLast Updated:March 7, 2023Active, not recruiting
Condition(s):Malignant Pleural EffusionLast Updated:November 7, 2018Unknown status
Condition(s):Head and Neck Squamous Cell CarcinomaLast Updated:July 28, 2023Not yet recruiting
Condition(s):Hereditary Hemorrhagic Telangiectasia (HHT)Last Updated:December 4, 2019Completed
Condition(s):Metastatic Colorectal CancerLast Updated:January 9, 2014Unknown status
Condition(s):Central Retinal Vein OcclusionLast Updated:October 26, 2020Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.